You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 19, 2025

List of Excipients in API dexmethylphenidate hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing dexmethylphenidate hydrochloride

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Novartis Pharmaceuticals Corporation FOCALIN dexmethylphenidate hydrochloride 0078-0380 CELLULOSE, MICROCRYSTALLINE
Novartis Pharmaceuticals Corporation FOCALIN dexmethylphenidate hydrochloride 0078-0380 FD&C BLUE NO. 1
Novartis Pharmaceuticals Corporation FOCALIN dexmethylphenidate hydrochloride 0078-0380 LACTOSE MONOHYDRATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing dexmethylphenidate hydrochloride

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc dexmethylphenidate hydrochloride 0093-5550 AMMONIO METHACRYLATE COPOLYMER TYPE B
Teva Pharmaceuticals USA Inc dexmethylphenidate hydrochloride 0093-5550 D&C YELLOW NO. 10 ALUMINUM LAKE
Teva Pharmaceuticals USA Inc dexmethylphenidate hydrochloride 0093-5550 FD&C BLUE NO. 1
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for dexmethylphenidate hydrochloride

Excipient focus: 1-PROPOXY-2-PROPANOL

Excipient focus: ACETONE

Excipient focus: ACETYLTRIBUTYL CITRATE

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: AMMONIO METHACRYLATE COPOLYMER TYPE A

Excipient focus: AMMONIO METHACRYLATE COPOLYMER TYPE B

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: D&C RED NO. 28

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: DEXTROSE

Excipient focus: DIMETHICONE

Excipient focus: ETHYLCELLULOSES

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 06081224

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHACRYLIC ACID

Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER

Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POVIDONE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRIETHYL CITRATE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links